Abstract:Piperine (PIP), the major alkaloid component from Piper longum L. and Piper nigrum L., could enhance the bioavailabilities of other drugs including rosuvastatin, peurarin and docetaxel (DOX) via inhibition of CYP3A and P-glycoprotein activity. Nevertheless, the effect of such drug combination usage on the in vivo exposure of PIP has not been investigated due to lack of assay for the simultaneous determination of PIP and other drugs such as DOX. Besides, the reported pharmacokinetics of PIP varied a lot without appropriate bioavailability determined from the same dose. In the current study, an LC/MS/MS method has been developed to simultaneously determine the plasma concentrations of PIP and DOX and further applied to investigate the pharmacokinetics properties of PIP after oral and intravenous administrations as well as the pharmacokinetics interactions between PIP and DOX after their co-administration. A simple protein precipitation method was employed for plasma sample treatment by adding a mixture of methanol and acetonitrile (1:1, v/v) with glibenclamide as internal standard (IS). The LC/MS/MS system consisted of Agilent 6430 series LC pumps and auto-sampler. The chromatographic separation was carried out in 15min on a Waters C18 column (150×3.9mm i.d., 4μm) with a mobile phase containing 0.2% formic acid and acetonitrile (1:1, v/v) at a flow rate of 0.4ml/min. The detection was performed using the positive ion electrospray ionization (ESI) in multiple reaction monitoring (MRM) mode with precursor-to-product ion transitions at m/z 286.1→201.1 for PIP, m/z 830.3→548.9 for DOX and m/z 494.2→369.0 for IS. The method demonstrated good linearity for both PIP and DOX over the concentration range of 2.5-1280ng/ml with LLOD at 2.5ng/ml. The intra-day and inter-day precisions were less than 13.34% and relative error (R.E.) representing accuracy was in the range of -11.38 to 3.15%. The recoveries of PIP, DOX and IS were above 75% and there was no matrix effect. PIP and DOX exhibited good stabilities under various conditions. PIP was administrated via intravenous bolus at 3.5mg/kg and via oral administration at 35mg/kg and 3.5mg/kg, while DOX was intravenously administrated at 7mg/kg to Sprague-Daley rats. The plasma concentrations of PIP and DOX were determined using the above developed and validated method. At the dose of 3.5mg/kg, the bioavailability of PIP was calculated to be 25.36%. Its AUC0→t was unproportionally increased with doses, indicating a potential non-linear pharmacokinetics profile of PIP. It was found that the AUC0→t and C0 of DOX and t1/2 of PIP were significantly increased after their combination use, suggesting potential enhanced bioavailability of not only DOX but also PIP, which may lead to the overall enhanced pharmacological effects.

Efficient Brain Uptake of Piperine and Its Pharmacokinetics Characterization after Oral Administration

Quantitative Itraq-Based Proteomic Analysis of Piperine Protected Cerebral Ischemia/reperfusion Injury in Rat Brain

Preparation, pungency and bioactivity transduction of piperine from black pepper (<i> Piper</i> nigrum L.): A comprehensive review

Progress in effects mechanism of piperine on the enhanced bioavailability of drugs

Non-linear Pharmacokinetics of Piperine and Its Herb-Drug Interactions with Docetaxel in Sprague-Dawley Rats.

Preparation, pungency and bioactivity transduction of piperine from black pepper (Piper nigrum L.): A comprehensive review

Piperine and Its Metabolite’s Pharmacology in Neurodegenerative and Neurological Diseases

Pharmacokinetic Drug Interactions of Piperine: A Review of Pre-clinical and Clinical Studies

Piperine As a Neuroprotective Functional Component in Rats with Cerebral Ischemic Injury

Pharmacokinetics of piperine from Piper longum in rats

Piperine-A Major Principle of Black Pepper: A Review of Its Bioactivity and Studies

Piperine: A comprehensive review of methods of isolation, purification, and biological properties

Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine after Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats

Effect of Piperine on Metablism and Distribution of Nortriptyline in Mice

Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat.

Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease.

Piperine: Chemistry and Biology

Piperine: Old Spice and New Nutraceutical?

Predicting Food–Drug Interactions between Piperine and CYP3A4 Substrate Drugs Using PBPK Modeling

Pharmacokinetics of piperine capsules in healthy volunteers

Anticonvulsant Effect of Piperine Ameliorates Memory Impairment, Inflammation and Oxidative Stress in a Rat Model of Pilocarpine-Induced Epilepsy.